About Lorraine Keller
Form D filings for MBF Therapeutics in 2024 list Lorraine Keller as executive officer.
Lorraine Keller first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Lorraine Keller in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Lorraine Keller works with at each company, as listed on that company's latest Form D.
MBF Therapeutics, Inc. · Form D, Jan 8, 2024
DT
Dhiren Thakker
Director
JC
Joseph Connor
Director
AP
Aris Persidis
Director
TT
Thomas Tillett
President and director
CC
Christopher Cashman
Director